Supply of the product Elevit with Iodine by Bayer Australia

Administered by Department of Health, Disability and Ageing

Legislation au C2014G00649 In force Gazette

Legislation content

COMMONWEALTH OF AUSTRALIA

Department of Health
Therapeutic Goods Administration

THERAPEUTIC GOODS ACT 1989

 

SECTIONS 14 and 14A NOTICE

 

On 14 April 2014, the Delegate of the Secretary of the Department of Health gave consent, pursuant to sections 14 and 14A of the Therapeutic Goods Act 1989 (the Act), to the following:

  1. The supply and importation  of the therapeutic goods or classes of therapeutic goods specified in Column 2 of the Table and with the Australian Register of Therapeutic Goods number (ARTG No.) specified in Column 3 of the Table; and
  2. Without conforming to those clauses, specified in Column 5 of the Table, of the standard, specified in the Column 4 of the Table otherwise applicable to the goods.

Pursuant to section 15(1) of the Act, consent is subject to the conditions specified in Column 6 of the Table and consent is given for the period specified in Column 7 of the Table, provided all other requirements of the standard are met.

Column 1

Column 2

Column3

Column 4

Column 5

Column 6

Column 7

Sponsor

Goods or Classes of Goods

ARTG No.

Standard

Clauses

Conditions

Period for which consent is given

Bayer Australia Ltd

Elevit with Iodine

Batch number 81647306 (100 tablet pack) and 81647276 (30 tablet pack) 

174543

TGO 78

11(b)

The limits of content of the each of the active ingredient must comply with limits stated in Table 1

 

The consent for importation and supply expires on 31 July 2014

Bayer Australia Ltd

Elevit with Iodine

Batch number 81647306 (100 tablet pack) and 81647276 (30 tablet pack) 

174543

TGO 78

11(c)

-

The consent for importation and supply expires on 31 July 2014

 

 

 

 

Table 1

Calcium

90 – 110%

Phosphorus

90 – 110%

Iodine

90 – 110%

Copper

90 – 125%

Iron

90 – 110%

Magnesium

90 – 110%

Zinc

90 – 110%

Folic acid

90 – 125%

Ascorbic acid

90 – 121%

Nicotinamide

90 – 115.5%

dl-alpha tocopheryl acetate

90 – 121%

Cholecalciferol

90 – 132%

Pyridoxine hydrochloride

90 – 121.2%

Calcium pantothenate

90 – 115.5%

Riboflavine

90 – 121.1%

Thiamine nitrate

87.5 – 117.5%

Cyanocobalamin

85 – 138%

Biotin

85 – 126.5%

 

 

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.